JPRN-UMIN000047956已完成未知
A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product - A Clinical Study to Evaluate the Efficacy, Safety and Consumer Perception of a Moisturizing Product
ION CORPORATIO0 个研究点目标入组 35 人开始时间: 2022年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a) Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control; b) Subject experiences repeated scratching that may cause raised areas on the skin which may bleed or become inflected due to the intense nature of the itch; c) Subject has hives; d) Subject has dense hair on the lower legs; e) Subject is a regular user of prescription itch relievers; f) Subject has used cosmetic itch relievers on the lower legs within one week prior to study start date; #VALUE! h) Subject has known allergies to cosmetics or toiletry products; i) Subject exhibits sunburn, rashes, scratches, burn marks, etc. on the test sites, or has tattoos or piercings which might interfere with study evaluations; j) Subject exhibits or reports a history of acute or chronic dermatological, medical, and/or physical conditions that would preclude application of the test material and/or could influence the outcome of the study; k) Subject has participated in a clinical study which involved the legs within one week of study initiation; l) Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind; m) Subject has diabetes.
研究者
相似试验
招募中
3 期
A Clinical Trial to Study the Effectiveness and Safety of Brinzolamide 1.0% w/v plus Brimonidine Tartrate 0.2 % w/v Ophthalmic Suspension compared with Brinzolamide 1% eye drops for the Treatment of patients with Open-Angle Glaucoma or Ocular Hypertension.CTRI/2015/07/006043Ajanta Pharma Ltd232
进行中（未招募）
不适用
Clinical Study to Investigate the Efficacy, Safety, and Immunogenicity of human-cl rhFVIII in Previously Treated Patients With Severe Haemophilia ASevere haemophilia A (FVIII:C <1%)EUCTR2009-011055-43-ATOctapharma AG32
进行中（未招募）
不适用
The main purpose of this study is to investigate the efficacy and safety of human-cl rhFVIII during prophylaxis but also if the patient needs treatment of spontaneous or traumatic bleeding episodes, and prior to and during or after surgery.EUCTR2009-011055-43-GBOctapharma AG32
进行中（未招募）
不适用
The main purpose of this study is to investigate the efficacy and safety of human-cl rhFVIII during prophylaxis but also if the patient needs treatment of spontaneous or traumatic bleeding episodes, and prior to and during or after surgery.Severe haemophilia A (FVIII:C <=1%)MedDRA version: 13.1Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2009-011055-43-DEOctapharma AG32
已完成
3 期
A clinical Trial in patients with Vernal Keratoconjunctivitis. Clinical trial is to study efficacy, safety and tolerability of Tacrolimus Ophthalmic Suspension in comparison to Cyclosporine eye drops (reference product).CTRI/2010/091/001456Ajanta Pharma Ltd200